Category 2022
1H		 2022
2H		 2023
1H		 2023
2H		 2024
1H		 2024
2H		 Target indication
BRIXELLE-INFLA
Acute inflammatory
disease		 IV
CMC, PK & Tox
IND Sub.
Phase I
Phase II
Ischemic Reperfusion Injury(Organ Transplant, AKI, AMI, CABG, Stroke)
Chronic inflammatory
disease		 SC/PO
Efficacy & MoA
Formulation dev.
PK & Tox
TBD
(MS, IBD, Asthma, etc.)
Skin
disease		 Topical
Efficacy & MoA
Formulation dev.
PK & Tox
Atopic dermatitis, Psoriasis, etc.
BRIXELLE-ONCO
Drug delivery system IV
DDS characterization
Efficacy & MoA
Formulation dev.
PK & Tox
Cancer
Discovery projects
Discovery
projects		 Project A
Discovery
Efficacy & MoA
 
Project B
Discovery
Efficacy
 
Project C
Discovery
 

If you are interested in our pipeline, please contact us.